Hamill Laura has filed 17 insider transactions across 3 companies since January 2023.
Most recent transaction: a disposition of 11000 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on September 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.02% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Employee Stock Option (right to buy) | 16000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.04% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Employee Stock Option (right to buy) | 33450 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.07% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Employee Stock Option (right to buy) | 14545 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Common Stock | 25080 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.06% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Employee Stock Option (right to buy) | 27000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.06% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | D | Employee Stock Option (right to buy) | 13950 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | U | Common Stock | 5825 | $8.60 | 0.0000 | 45,318,028 | 100.00% | 0.01% |
| Aug. 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Hamill Laura | Director | A | Ordinary Shares | 3507 | $0.00 | 8,738.0000 | 66,007,000 | 67.04% | 0.01% |
| Aug. 8, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Hamill Laura | Director | F | Ordinary Shares | 1805 | $111.25 | 6,933.0000 | 66,007,000 | 20.66% | 0.00% |
| June 30, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | A | Common Stock | 25080 | $0.00 | 30,905.0000 | 45,104,476 | 430.56% | 0.06% |
| June 30, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Not found | A | Employee Stock Option (right to buy) | 33450 | $0.00 | 33,450.0000 | 45,104,476 | 9999.99% | 0.07% |
| Aug. 2, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Hamill Laura | Director | A | Ordinary Shares | 3731 | $0.00 | 5,231.0000 | 72,066,000 | 248.73% | 0.01% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Director | A | Employee Stock Option (right to buy) | 14545 | $0.00 | 14,545.0000 | 43,779,456 | 9999.99% | 0.03% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | Hamill Laura | Director | A | Common Stock | 3495 | $0.00 | 5,825.0000 | 43,779,456 | 150.00% | 0.01% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Hamill Laura | Director | A | Stock Option (right to buy) | 10600 | $0.00 | 10,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Hamill Laura | Director | A | Restricted Stock Unit | 3900 | $0.00 | 3,900.0000 | 0 | 9999.99% | 0.00% |